Investors

Insider Transactions

Date Name Sorted Descending Title Type Shares Traded Price Range
Sep 30, 2008 stahl neil Officer Sell 10,317 21.50 - 22.15
Sep 29, 2008 stahl neil Officer Option Execute 25,000 8.77
Sep 29, 2008 stahl neil Officer Disposition (Non Open Market) 14,683 23.28
Nov 18, 2015 sing george l Director Option Execute 3,000 19.69
Nov 18, 2015 sing george l Director Sell 500 580.00
Nov 18, 2015 sing george l Director Sell 3,000 580.00
May 27, 2015 sing george l Director Option Execute 5,000 19.69
May 27, 2015 sing george l Director Sell 5,000 515.00
Feb 20, 2015 sing george l Director Option Execute 15,000 18.61
Feb 20, 2015 sing george l Director Sell 15,000 423.12
Feb 21, 2014 sing george l Director Option Execute 15,000 15.80
Feb 21, 2014 sing george l Director Sell 15,000 338.00 - 340.00
Feb 14, 2014 sing george l Director Option Execute 15,000 9.17
Feb 14, 2014 sing george l Director Sell 15,000 324.00
Nov 26, 2013 sing george l Director Option Execute 10,000 15.01
Nov 26, 2013 sing george l Director Sell 10,000 295.00
May 10, 2013 sing george l Director Option Execute 5,000 15.01
May 10, 2013 sing george l Director Sell 5,000 270.00
Dec 17, 2012 sing george l Director Acquisition (Non Open Market) 10,000 n/a
Dec 17, 2012 sing george l Director Disposition (Non Open Market) 10,000 n/a
Showing 301-320 of 1043 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)